Psoriasis trials in United States
69 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.
- No phaseTaking peopleMediterranean Diet vs no Dietary Intervention for Improving Signs and Symptoms of Psoriasis in Patients Treated With Anti-IL-17 or Anti-IL-23 Inhibitors
- Where
- Cleveland
- Age
- 18 years to 94 years
- People
- 36
- Run by
- University Hospitals Cleveland Medical Center
See details and how to joinNCT06399432 - Phase 3Taking peopleA Study to Assess Adverse Events, Change in Disease Activity, and How the Drug Moves Through the Body in Children With Juvenile Psoriatic Arthritis (jPsA) Receiving Subcutaneously Injected Risankizumab or Adalimumab
- Where
- Austin, Chapel Hill, Cleveland, Hollywood, Indianapolis, Little Rock, Miami, Minneapolis, New York, Valhalla, Washington D.C.
- Age
- 5 years to 17 years
- People
- 40 worldwide
- Run by
- AbbVie
See details and how to joinNCT06100744 · EU 2023-506026-36-00 - Phase 4Taking peopleDeucravacitinib-TNFi Combination Therapy for Difficult-to-Control Psoriatic Disease
- Where
- Dallas
- Age
- 18 years to 65 years
- People
- 128
- Run by
- University of Texas Southwestern Medical Center
See details and how to joinNCT07280702 - No phaseTaking peopleThe CorEvitas Psoriasis (PSO) Registry
- Where
- Waltham
- Age
- 18 years and over
- People
- 10,000
- Run by
- CorEvitas
See details and how to joinNCT02707341 - No phaseTaking peoplePPD™ CorEvitas™ Psoriasis (PSO) Rapid Response Non-Interventional Study
- Where
- Waltham
- Age
- 18 years and over
- People
- 2,500
- Run by
- CorEvitas
See details and how to joinNCT07615712 - No phaseTaking peoplePPD™ CorEvitas™ Psoriasis (PSO) Early Treatment Response Non-Interventional Study
- Where
- Waltham
- Age
- 18 years and over
- People
- 2,500
- Run by
- CorEvitas
See details and how to joinNCT07648602 - No phaseTaking peopleCreating Health Course Study for People With Rheumatological Conditions and Mood Disorders
- Where
- Iowa City
- Age
- 18 years to 100 years
- People
- 400
- Run by
- Terry L. Wahls
See details and how to joinNCT07180537 - Phase 4Not yet taking people in United StatesA Clinical Trial of Antiplatelets in Psoriasis
- Where
- New York
- Age
- 18 years to 90 years
- People
- 60
- Run by
- NYU Langone Health
See details and how to joinNCT07744191 - Phase 2/3Enrolling by invitationComparison of Post-Inflammatory Pigment Alteration After Psoriasis Treatment (PIPA - Dermavant)
- Where
- Winston-Salem
- Age
- 18 years and over
- People
- 40
- Run by
- Wake Forest University Health Sciences
See details and how to joinNCT05981118 - No phaseTaking peopleThe Effects of Audio-Based Therapy on Anxiety in Psoriasis
- Where
- San Francisco
- Age
- 18 years and over
- People
- 120
- Run by
- University of California, San Francisco
See details and how to joinNCT07390487 - No phaseTaking peopleSkin Microbial Ecology in Atopic Dermatitis
- Where
- Rochester
- Age
- 13 years and over
- People
- 240
- Run by
- University of Rochester
See details and how to joinNCT04170244 - Phase 2Taking peopleImmunosuppressant Management in Rheumatology Patients Undergoing Elective Total Shoulder Arthroplasty
- Where
- New York
- Age
- 18 years and over
- People
- 80
- Run by
- NYU Langone Health
See details and how to joinNCT07138898 - Phase 2Taking peopleA Study to Evaluate D-2570 in Participants With Moderate to Severe Plaque Psoriasis
- Where
- Birmingham, Chula Vista, Clarksville, Fort Lauderdale, Fountain Valley, Fremont, Idaho Falls, Los Angeles, Louisville, Mayfield Heights, Miramar, Ocala, Philadelphia, Phoenix, San Antonio, San Diego, Sandy Springs, Savannah, Tampa
- Age
- 18 years to 70 years
- People
- 75
- Run by
- InventisBio Co., Ltd
See details and how to joinNCT07489885 - No phaseTaking peopleUse of Total-Body PET to Quantify Systemic and Cutaneous Inflammation in Psoriasis Patients Before and After Intervention With a Nutritionally Balanced Diet
- Where
- Sacramento
- Age
- 18 years and over
- People
- 5
- Run by
- University of California, Davis
See details and how to joinNCT06574178 - No phaseTaking peopleElucidating Shared Mechanisms Contributing to NAFLD and PsA Disease Severity With Guselkumab Therapy
- Where
- San Diego
- People
- 20
- Run by
- University of California, San Diego
See details and how to joinNCT06586281 - Phase 4Taking peoplePsoriatic Immune Response to Tildrakizumab
- Where
- San Francisco
- Age
- 18 years to 75 years
- People
- 10
- Run by
- University of California, San Francisco
See details and how to joinNCT05390515 - Phase 4Taking peopleImmune Spatial Features of Guselkumab Cutaneous Response
- Where
- San Francisco
- Age
- 18 years and over
- People
- 10
- Run by
- University of California, San Francisco
See details and how to joinNCT05858632 - Phase 4Taking peopleCorrection of Psoriatic T Cell Signatures by Deucravacitinib
- Where
- San Francisco
- Age
- 18 years to 75 years
- People
- 25
- Run by
- University of California, San Francisco
See details and how to joinNCT05858645 - Phase 4Not yet taking people in United StatesUtilization of a Microdevice for Psoriasis and Atopic Dermatitis
- Where
- San Francisco
- Age
- 18 years and over
- People
- 10
- Run by
- University of California, San Francisco
See details and how to joinNCT07352566 - No phaseTaking peopleTesting of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors
- Where
- Houston
- Age
- 18 years and over
- People
- 125
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT04751396 - No phaseTaking peopleRegulation of Inflammatory Genes in Psoriasis
- Where
- Birmingham
- Age
- 19 years to 99 years
- People
- 13
- Run by
- University of Alabama at Birmingham
See details and how to joinNCT03125655 - Phase 4Taking peopleA Study to Evaluate the Impact of Upadacitinib on Spondyloarthritis Outcomes in Patients With Active Psoriatic Arthritis
- Where
- Cleveland, Philadelphia, Portland
- Age
- 18 years and over
- People
- 100 worldwide
- Run by
- CARE ARTHRITIS LTD.
See details and how to joinNCT06454188 · EU 2023-510242-24-00 - Phase 4Taking peopleDevelopment of Predictive Psoriasis Response Endotypes Using Single Cell Transcriptomics
- Where
- Cleveland
- Age
- 18 years to 89 years
- People
- 56
- Run by
- University Hospitals Cleveland Medical Center
See details and how to joinNCT05270733 - Phase 4Taking peopleMulti-Center PAMPA Study
- Where
- Boston, New York, Rochester
- Age
- 18 years and over
- People
- 176 worldwide
- Run by
- NYU Langone Health
See details and how to joinNCT05004727 - No phaseTaking peopleA Study to Evaluate the Impact of a Magnolia Officinalis Dietary Supplement on Immune Biomarkers in Subjects With Psoriasis
- Where
- Englewood
- Age
- 18 years and over
- People
- 100
- Run by
- Sirt3 LLC
See details and how to joinNCT07471048